- Report
- April 2023
- 120 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- April 2023
- 110 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- April 2023
- 114 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- April 2023
- 110 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- April 2023
- 116 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2022
- 115 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- October 2023
- 161 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- January 2025
- 85 Pages
India
From €3317EUR$3,500USD£2,799GBP
- Report
- December 2024
- 82 Pages
Vietnam
From €3317EUR$3,500USD£2,799GBP
- Report
- January 2024
- 182 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- November 2023
- 175 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- October 2023
- 190 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- October 2023
- 189 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- May 2023
- 169 Pages
Global
From €7576EUR$7,995USD£6,394GBP
- Report
- May 2022
- 167 Pages
Global
From €1848EUR$1,950USD£1,559GBP
- Report
- January 2024
- 425 Pages
Global
From €3411EUR$3,600USD£2,879GBP
- Report
- January 2024
- 183 Pages
Middle East, Africa
From €1421EUR$1,500USD£1,200GBP
- Report
- January 2024
- 163 Pages
North America
From €1421EUR$1,500USD£1,200GBP
- Report
- January 2024
- 187 Pages
Europe
From €1421EUR$1,500USD£1,200GBP
- Report
- January 2024
- 189 Pages
Asia Pacific
From €1421EUR$1,500USD£1,200GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more